Increased burn patient survival with individualized dosage of gentamicin

D. E. Zaske, J Lyle Bootman, L. B. Solem, R. G. Strate

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

The clinical effect of measuring serum gentamicin concentrations and individualizing each patient's dosage regimen was determined in 105 burn patients with severe gram-negative sepsis. Thirty-nine patients (conventionally dosed group) received the recommended dosage regimen of 3 to 5 mg/kg/day from 1972 to 1974. From 1974 to 1976, serum concentrations were measured in 66 patients (individually dosed group), and each patient's dose was individually calculated to obtain therapeutic serum concentrations. All patients had normal renal function prior to initiation of gentamicin therapy. For each group, 16 independent variables were compared that may have influenced treatment response. The patients in the individually dosed group required an average dose of 7.4 mg/kg/day to achieve therapeutic concentrations, compared to the average dose of 4.4 mg/kg/day for the patients receiving conventional doses (P < 0.001). An abrupt increase in patient survival occurred with the implementation of individualized regimens. Patient survival rates for the entire hospital course were 33% and 64% for the conventionally dosed and individually dosed groups, respectively (P < 0.005). Survival rates for the first septic episode were 51.3% and 86.4%, respectively (P < 0.001). Individualized gentamicin regimens, age, percent burn, and sex were the statistically significant variables related to patient survival for the first episode of sepsis. Age, percent burn, individualized dosing, complications during hospitalization, and a positive blood culture were significant factors related to patient survival for the entire hospital course. These data confirm the need for measuring serum gentamicin concentrations and adjusting dosages to ensure therapeutic levels and maximal efficacy of gentamicin in burn patients.

Original languageEnglish (US)
Pages (from-to)142-149
Number of pages8
JournalSurgery
Volume91
Issue number2
StatePublished - 1982
Externally publishedYes

Fingerprint

Gentamicins
Survival
Serum
Sepsis
Survival Rate
Therapeutics
Hospitalization

ASJC Scopus subject areas

  • Surgery

Cite this

Zaske, D. E., Bootman, J. L., Solem, L. B., & Strate, R. G. (1982). Increased burn patient survival with individualized dosage of gentamicin. Surgery, 91(2), 142-149.

Increased burn patient survival with individualized dosage of gentamicin. / Zaske, D. E.; Bootman, J Lyle; Solem, L. B.; Strate, R. G.

In: Surgery, Vol. 91, No. 2, 1982, p. 142-149.

Research output: Contribution to journalArticle

Zaske, DE, Bootman, JL, Solem, LB & Strate, RG 1982, 'Increased burn patient survival with individualized dosage of gentamicin', Surgery, vol. 91, no. 2, pp. 142-149.
Zaske, D. E. ; Bootman, J Lyle ; Solem, L. B. ; Strate, R. G. / Increased burn patient survival with individualized dosage of gentamicin. In: Surgery. 1982 ; Vol. 91, No. 2. pp. 142-149.
@article{1cfff8e9538f45a5957d0c195924d6aa,
title = "Increased burn patient survival with individualized dosage of gentamicin",
abstract = "The clinical effect of measuring serum gentamicin concentrations and individualizing each patient's dosage regimen was determined in 105 burn patients with severe gram-negative sepsis. Thirty-nine patients (conventionally dosed group) received the recommended dosage regimen of 3 to 5 mg/kg/day from 1972 to 1974. From 1974 to 1976, serum concentrations were measured in 66 patients (individually dosed group), and each patient's dose was individually calculated to obtain therapeutic serum concentrations. All patients had normal renal function prior to initiation of gentamicin therapy. For each group, 16 independent variables were compared that may have influenced treatment response. The patients in the individually dosed group required an average dose of 7.4 mg/kg/day to achieve therapeutic concentrations, compared to the average dose of 4.4 mg/kg/day for the patients receiving conventional doses (P < 0.001). An abrupt increase in patient survival occurred with the implementation of individualized regimens. Patient survival rates for the entire hospital course were 33{\%} and 64{\%} for the conventionally dosed and individually dosed groups, respectively (P < 0.005). Survival rates for the first septic episode were 51.3{\%} and 86.4{\%}, respectively (P < 0.001). Individualized gentamicin regimens, age, percent burn, and sex were the statistically significant variables related to patient survival for the first episode of sepsis. Age, percent burn, individualized dosing, complications during hospitalization, and a positive blood culture were significant factors related to patient survival for the entire hospital course. These data confirm the need for measuring serum gentamicin concentrations and adjusting dosages to ensure therapeutic levels and maximal efficacy of gentamicin in burn patients.",
author = "Zaske, {D. E.} and Bootman, {J Lyle} and Solem, {L. B.} and Strate, {R. G.}",
year = "1982",
language = "English (US)",
volume = "91",
pages = "142--149",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Increased burn patient survival with individualized dosage of gentamicin

AU - Zaske, D. E.

AU - Bootman, J Lyle

AU - Solem, L. B.

AU - Strate, R. G.

PY - 1982

Y1 - 1982

N2 - The clinical effect of measuring serum gentamicin concentrations and individualizing each patient's dosage regimen was determined in 105 burn patients with severe gram-negative sepsis. Thirty-nine patients (conventionally dosed group) received the recommended dosage regimen of 3 to 5 mg/kg/day from 1972 to 1974. From 1974 to 1976, serum concentrations were measured in 66 patients (individually dosed group), and each patient's dose was individually calculated to obtain therapeutic serum concentrations. All patients had normal renal function prior to initiation of gentamicin therapy. For each group, 16 independent variables were compared that may have influenced treatment response. The patients in the individually dosed group required an average dose of 7.4 mg/kg/day to achieve therapeutic concentrations, compared to the average dose of 4.4 mg/kg/day for the patients receiving conventional doses (P < 0.001). An abrupt increase in patient survival occurred with the implementation of individualized regimens. Patient survival rates for the entire hospital course were 33% and 64% for the conventionally dosed and individually dosed groups, respectively (P < 0.005). Survival rates for the first septic episode were 51.3% and 86.4%, respectively (P < 0.001). Individualized gentamicin regimens, age, percent burn, and sex were the statistically significant variables related to patient survival for the first episode of sepsis. Age, percent burn, individualized dosing, complications during hospitalization, and a positive blood culture were significant factors related to patient survival for the entire hospital course. These data confirm the need for measuring serum gentamicin concentrations and adjusting dosages to ensure therapeutic levels and maximal efficacy of gentamicin in burn patients.

AB - The clinical effect of measuring serum gentamicin concentrations and individualizing each patient's dosage regimen was determined in 105 burn patients with severe gram-negative sepsis. Thirty-nine patients (conventionally dosed group) received the recommended dosage regimen of 3 to 5 mg/kg/day from 1972 to 1974. From 1974 to 1976, serum concentrations were measured in 66 patients (individually dosed group), and each patient's dose was individually calculated to obtain therapeutic serum concentrations. All patients had normal renal function prior to initiation of gentamicin therapy. For each group, 16 independent variables were compared that may have influenced treatment response. The patients in the individually dosed group required an average dose of 7.4 mg/kg/day to achieve therapeutic concentrations, compared to the average dose of 4.4 mg/kg/day for the patients receiving conventional doses (P < 0.001). An abrupt increase in patient survival occurred with the implementation of individualized regimens. Patient survival rates for the entire hospital course were 33% and 64% for the conventionally dosed and individually dosed groups, respectively (P < 0.005). Survival rates for the first septic episode were 51.3% and 86.4%, respectively (P < 0.001). Individualized gentamicin regimens, age, percent burn, and sex were the statistically significant variables related to patient survival for the first episode of sepsis. Age, percent burn, individualized dosing, complications during hospitalization, and a positive blood culture were significant factors related to patient survival for the entire hospital course. These data confirm the need for measuring serum gentamicin concentrations and adjusting dosages to ensure therapeutic levels and maximal efficacy of gentamicin in burn patients.

UR - http://www.scopus.com/inward/record.url?scp=0020079002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020079002&partnerID=8YFLogxK

M3 - Article

C2 - 7058491

AN - SCOPUS:0020079002

VL - 91

SP - 142

EP - 149

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 2

ER -